Kronos Early Estrogen Prevention Study (KEEPS)

Bio2RDF uri

Kronos Early Estrogen Prevention Study (KEEPS)

http://bio2rdf.org/clinicaltrials:NCT00154180

Bio2RDF identifier

NCT00154180

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00154180

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00154180

anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]

728

http://www.w3.org/2001/XMLSchema#integer

arm group [clinicaltrials_vocabulary:arm-group]

NCT00154180 arm group 0a6e71b1034abcd1f2d32e915b9fecee [clinicaltrials_resource:NCT00154180/arm-group/0a6e71b1034abcd1f2d32e915b9fecee]

NCT00154180 arm group 3f237303121a9d19106f8a7fd915e494 [clinicaltrials_resource:NCT00154180/arm-group/3f237303121a9d19106f8a7fd915e494]

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:ca1954f55de6b13c270f49787460e895

brief summary [clinicaltrials_vocabulary:brief-summary]

The study will examine ...... the menopausal transition.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Kronos Early Estrogen Prevention Study (KEEPS)

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Rate of change of carotid intimal medial thickness by ultrasound Measured at screening, 12, 24, 36, and 48 months [clinicaltrials_resource:181a9b4c84a2923ebdf603f1bb86877f]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Rate of change of carotid intimal medial thickness by ultrasound Measured at screening, 12, 24, 36, and 48 months [clinicaltrials_resource:00bbb042c8d3f5d7a16e3f0dd4ad8706]

Rate of change of carotid intimal medial thickness by ultrasound Measured at screening, 12, 24, 36, and 48 months [clinicaltrials_resource:1ae819d138963de7a5dcf386fa9914d3]

Rate of change of carotid intimal medial thickness by ultrasound Measured at screening, 12, 24, 36, and 48 months [clinicaltrials_resource:1c89b05a05d883b3e2106f6c5ca40152]

Rate of change of carotid intimal medial thickness by ultrasound Measured at screening, 12, 24, 36, and 48 months [clinicaltrials_resource:52214c5a5a2d32ca29e9898200ebb912]

Rate of change of carotid intimal medial thickness by ultrasound Measured at screening, 12, 24, 36, and 48 months [clinicaltrials_resource:5b4926f6b9c97b09fb3b1dbf8895e6b7]

Rate of change of carotid intimal medial thickness by ultrasound Measured at screening, 12, 24, 36, and 48 months [clinicaltrials_resource:6a2fa8247cc2ae87860c7ff13e3f4535]

Rate of change of carotid intimal medial thickness by ultrasound Measured at screening, 12, 24, 36, and 48 months [clinicaltrials_resource:7b233318e2280aa6abde608dcbde5f25]

collaborator [clinicaltrials_vocabulary:collaborator]

Kronos Longevity Research Institute [clinicaltrials_resource:7c7b7ebcdb78bc64fa292c66c68f6441]

completion date [clinicaltrials_vocabulary:completion-date]

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

detailed description [clinicaltrials_vocabulary:detailed-description]

The KEEPS is designed t ...... pletion of the trial in 2010.

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00154180 [clinicaltrials_resource:f5f9d95488c007cb5d179711566bc785]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2005-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

Conjugated equine estrogens 0.45 mg/day [clinicaltrials_resource:12a13c92dd6fa77ccce99a4aa0985d25]

CEE, progesterone, transdermal patch or the placebo [clinicaltrials_resource:1ac499010c3244f80260f818256d1724]

Micronized progesterone, 200 mg/day x 12 d/month [clinicaltrials_resource:1d1431504f2dbf34479e7f14df35e789]

Transdermal estradiol, 50 mcg/day [clinicaltrials_resource:324b2a6dfc415cebc3565465187a121f]

CEE , progesterone, estradiol patch or placebo for each [clinicaltrials_resource:d3d6deff6807d067986fd70433ee9534]

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Progesterone [clinicaltrials_resource:0414e57c6aade7ec805b9e7f2c5b4a5e]

Estrogens [clinicaltrials_resource:0d1c3ec39682acea394f23ec05f183d5]

Estradiol 3-benzoate [clinicaltrials_resource:350b51592b9774b3f30685e19c911ecf]

Estrogens, Conjugated (USP) [clinicaltrials_resource:65fab4c4072a8860177ea4ae1259b399]

Polyestradiol phosphate [clinicaltrials_resource:6f84a00385bb3d23b3c7c62da0e7c3e6]

Estradiol 17 beta-cypionate [clinicaltrials_resource:91d0b0a56aceba5ea2ad10a738232593]

Estradiol [clinicaltrials_resource:a300cd65200686a5341ea728e79a7118]

Estradiol valerate [clinicaltrials_resource:d6938b287155c7009daa59f26186275b]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

Yes

http://www.w3.org/2001/XMLSchema#string

is section 801 [clinicaltrials_vocabulary:is-section-801]

Yes

http://www.w3.org/2001/XMLSchema#string

keyword [clinicaltrials_vocabulary:keyword]

Coronary Disease

http://www.w3.org/2001/XMLSchema#string

Estrogen Replacement Therapy

http://www.w3.org/2001/XMLSchema#string

Hormone Replacement Therapy

http://www.w3.org/2001/XMLSchema#string

Perimenopause

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2009-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Kronos Longevity Research Institute [clinicaltrials_resource:7c7b7ebcdb78bc64fa292c66c68f6441]

link [clinicaltrials_vocabulary:link]

Information on sponsoring institution [clinicaltrials_resource:49c338a8b1a6071ae5b34438c2125ea0]

Information on hormone treatment and KEEPS rationale [clinicaltrials_resource:c3c837762a2202b1706cca16282f6a37]

location [clinicaltrials_vocabulary:location]

Kronos Longevity Research Institute [clinicaltrials_resource:c1da355fe9589954b25c06173fdcdfd8]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00154180

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

Effects of Estrogen Replacemen ...... n in Recently Menopausal Women

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

KLRI-04-1

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

S Mitchell Harman, MD, PhD [clinicaltrials_resource:b409c1fff96fbbcb40980dad5c0d857e]

overall status [clinicaltrials_vocabulary:overall-status]

Active, not recruiting [clinicaltrials_resource:a6bc1606956390bcd6a391faced78809]

oversight [clinicaltrials_vocabulary:oversight]

United States: Institutional Review Board [clinicaltrials_resource:b5a2933cbbd357d5860e15ecc488e5c1]

phase [clinicaltrials_vocabulary:phase]

Phase 4 [clinicaltrials_resource:ec41833bc88cd90619c4d85c549688bd]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

reference [clinicaltrials_vocabulary:reference]

15542885 [pubmed:15542885]

15804727 [pubmed:15804727]

16024750 [pubmed:16024750]

responsible party [clinicaltrials_vocabulary:responsible-party]

S. Mitchell Harman, MD, PhD/Director, Kronos Longevity Research Institute [clinicaltrials_resource:7273513ce789fa97563dbe1508b869ef]

secondary id [clinicaltrials_vocabulary:secondary-id]

WIRB Protocol #20040792

http://www.w3.org/2001/XMLSchema#string

source [clinicaltrials_vocabulary:source]

Kronos Longevity Research Institute [clinicaltrials_resource:7c7b7ebcdb78bc64fa292c66c68f6441]

start date [clinicaltrials_vocabulary:start-date]

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00154180 study design [clinicaltrials_resource:d99f5ef01c8119eed541e71a5ed028c0]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00154180

verification date [clinicaltrials_vocabulary:verification-date]

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00154180

http://www.w3.org/2001/XMLSchema#string